Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction

Very-low-density lipoproteins (VLDL) is a hallmark of metabolic syndrome (MetS) and each manifestation of MetS is related to atrial fibrillation (AF) risks. Slowed atrial conduction is a mechanism of AF in MetS. We hypothesized that VLDL can modulate and reduce atrial gap junctions. VLDLs were separ...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Sci Rep
Prif Awduron: Lee, Hsiang-Chun, Chen, Chih-Chieh, Tsai, Wei-Chung, Lin, Hsin-Ting, Shiao, Yi-Lin, Sheu, Sheng-Hsiung, Wu, Bin-Nan, Chen, Chu-Huang, Lai, Wen-Ter
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group UK 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5608762/
https://ncbi.nlm.nih.gov/pubmed/28935953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-11416-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg